Accessibility helpSkip to navigationSkip to contentSkip to footer

Cookies on FT Sites

We use cookies and other data for a number of reasons, such as keeping FT Sites reliable and secure, personalising content and ads, providing social media features and to analyse how our Sites are used.

Accept cookies
Manage cookies
  • Sign In
  • Subscribe
Open side navigation menuOpen search bar
Financial Times
SubscribeSign InmyFT
  • Home
  • World
    Sections
    • World Home
    • Global Economy
    • UK
    • US
    • China
    • Africa
    • Asia Pacific
    • Emerging Markets
    • Europe
    • War in Ukraine
    • Americas
    • Middle East & North Africa
    • Australia & NZ
    Most Read
    • Donald Trump indicted on criminal charges in New York
    • ‘Dare to fight’: Xi Jinping unveils China’s new world order
    • Donald Trump to surrender to New York prosecutors on Tuesday
    • Donald Trump indictment thrusts a divided nation into new chapter of chaos
    • China’s envoy warns EU of ‘peril’ from following US on trade curbs
  • UK
    Sections
    • UK Home
    • UK Business & Economy
    • UK Politics & Policy
    • Brexit
    • UK Companies
    • Personal Finance
    Most Read
    • UK house prices post steepest fall since 2009
    • UK strikes agreement to join Asia-Pacific trade bloc
    • UK government threatened with legal action over Australia trade deal
    • UK minimum wage to increase 9.7% in ‘real-terms pay boost’
    • UK admits revised net zero strategy will fail to hit emission targets
  • Companies
    Sections
    • Companies Home
    • Banks in turmoil
    • Energy
    • Financials
    • Health
    • Industrials
    • Media
    • Professional Services
    • Retail & Consumer
    • Tech Sector
    • Telecoms
    • Transport
    Most Read
    • Colm Kelleher: Irish financial crisis veteran orchestrating Credit Suisse takeover
    • How rising interest rates are exposing bank weaknesses
    • UK is global equity markets ‘backwater’, Nick Train warns
    • Dealmaking at 10-year low in first quarter as bank crisis hits confidence
    • Virgin Orbit shares plunge after announcing ‘ceased operations’
  • Tech
  • Markets
    Sections
    • Markets Home
    • Alphaville
    • Markets Data
    • Cryptofinance
    • Capital Markets
    • Commodities
    • Currencies
    • Equities
    • Fund Management
    • Trading
    • Moral Money
    • ETF Hub
    Most Read
    • Prepare for a multipolar currency world
    • Live news: S&P cuts Turkey’s outlook to negative due to ‘untenable’ economic policies
    • Flood of cash into US money market funds could add to banking strains
    • How rising interest rates are exposing bank weaknesses
    • UK is global equity markets ‘backwater’, Nick Train warns
  • Climate
  • Opinion
    Sections
    • Opinion Home
    • Columnists
    • The FT View
    • Lex
    • Obituaries
    • Letters
    Most Read
    • Prepare for a multipolar currency world
    • Why are Americans dying so young?
    • We are living through a trillion-dollar rebalancing
    • Law versus man: Trump’s courtroom drama begins
    • Multiple red flags are not yet slowing the generative AI train
  • Work & Careers
    Sections
    • Work & Careers Home
    • Business School Rankings
    • Business Education
    • Entrepreneurship
    • Recruitment
    • Business Books
    • Business Travel
    Most Read
    • Boomerang chief executives provide comfort in times of crisis
    • Matthew Desmond: ‘America does so much more to subsidise affluence than alleviate poverty’
  • Life & Arts
    Sections
    • Life & Arts Home
    • Arts
    • Books
    • Food & Drink
    • FT Magazine
    • House & Home
    • Style
    • Travel
    • FT Globetrotter
    Most Read
    • I used AI to bet on horse-racing. Here’s what happened
    • Serhiy Prytula: ‘The defence minister said: “Try to buy a satellite.” I thought he was joking’
    • Gwyneth Paltrow, ‘stealth wealth’ star of the courtroom catwalk
    • It’s morally repugnant, but isolationism on Ukraine makes some sense
    • The big new trends from Watches and Wonders 2023
  • HTSI
MenuSearch
  • Home
  • World
  • UK
  • Companies
  • Tech
  • Markets
  • Climate
  • Opinion
  • Work & Careers
  • Life & Arts
  • HTSI
Financial Times
SubscribeSign In

US opioid epidemic

Add to myFT Digest

Add this topic to your myFT Digest for news straight to your inbox

  • Sunday, 12 March, 2023
    News in-depthMexico
    US turns up heat on Mexico after cartel kidnappings

    Deaths of US citizens and steeply rising fentanyl casualties prompt rising frustration in Washington

  • Monday, 20 February, 2023
    News in-depthFT Investigations
    Oxford university stuck with Sacklers as opioid deaths led others to cut ties

    Documents show privileged access to the Boat Race and continued acceptance of donations

  • Sunday, 22 January, 2023
    US warns overdose crisis will spread overseas without action from China

    White House drugs tsar says Beijing needs to tighten rules on supply of raw materials to make fentanyl

  • Thursday, 19 January, 2023
    The Oscars 2023: all you need to know
    Laura Poitras on Nan Goldin and their film taking on the opioid crisis

    The director discusses the fight to expose the Sackler family’s ‘artwashing’ of a fortune built on addictive drugs

  • Thursday, 29 December, 2022
    AmerisourceBergen slapped with federal lawsuit over opioids crisis

    Drug distributor knew pills were likely being sold in parking lots for cash, allege prosecutors

  • Tuesday, 15 November, 2022
    Walmart Inc
    Walmart lifts guidance as richer consumers go bargain hunting

    Retailer upgrades outlook even as $3.1bn opioids settlement results in quarterly net loss

  • Tuesday, 8 November, 2022
    US to boost medication access to tackle opioid overdose crisis

    Legal, societal and financial barriers block treatments that can reduce risk of overdose

  • Wednesday, 2 November, 2022
    US pharmacy groups CVS and Walgreens agree $10bn opioid settlements

    Other chains also in talks over claims linked to their roles in crisis

  • Thursday, 8 September, 2022
    Edward Luce
    America’s indifference to its death crisis

    The enduring drivers of the country’s morbid trajectory — rising obesity, the opioid epidemic and Covid — are hard to confront

  • Monday, 5 September, 2022
    Venice Film Festival 2022
    Five stars for opioid epidemic documentary All the Beauty and the Bloodshed

    Laura Poitras’s film is both a biography of artist Nan Goldin and an indictment of the Sackler family

  • Friday, 26 August, 2022
    Data PointsJohn Burn-Murdoch
    How US life expectancy fell off a cliff

    One factor explains why a gulf has opened between America and its wealthy peers: deaths from drug overdoses

  • Wednesday, 15 June, 2022
    InterviewOffice of National Drug Control Policy
    US pivots to ‘harm reduction’ after 107,000 overdose deaths last year

    White House drug tsar says marijuana legalisation and safe injection sites will also be reviewed

  • Wednesday, 27 April, 2022
    Pharmaceuticals sector
    McKinsey rebuts conflict claims over work for health regulator and opioid makers

    Congressional probe found 22 consultants had advised both the US FDA and drug manufacturers over a decade

  • Thursday, 3 March, 2022
    Purdue Pharma LP
    Purdue and US states agree new $6bn settlement for opioid litigation

    Members of Sackler family who owned OxyContin maker will increase financial contribution but still receive a legal shield

  • Friday, 18 February, 2022
    Sackler owners offer up to $6bn to settle Purdue Pharma bankruptcy

    Proposal revealed by court mediator comes after a judge rejected earlier deal

  • Wednesday, 16 February, 2022
    LexIndivior PLC
    Indivior: opioid treatment specialist is out of rehab Premium content

    The pharmaceuticals company has returned to financial health and is exploring a dual UK-US listing

  • Tuesday, 4 January, 2022
    The Big Read
    Will overdose deaths force an end to the US ‘war on drugs’?

    With more than 270 people dying every day, authorities are under pressure to treat, rather than prosecute, users

  • Friday, 17 December, 2021
    Judge overturns $4.5bn opioid-related settlement in Purdue Pharma bankruptcy

    Sackler family was to make multibillion-dollar contribution in exchange for protection from lawsuits

  • Thursday, 9 December, 2021
    Sackler name to be removed from Metropolitan Museum of Art galleries

    Move is the latest fallout for members of the family that owned opioid maker Purdue Pharma

  • Tuesday, 23 November, 2021
    Federal jury finds US pharmacy chains liable for opioid epidemic

    Ohio ruling is first time CVS, Walgreens and Walmart have been held culpable at conclusion of a trial

  • Friday, 12 November, 2021
    US Food & Drug Administration
    Biden’s nominee to lead FDA encounters pushback from some Democrats

    Concerns raised over Robert Califf’s previous stint at the US drugs regulator and its approach to the opioid epidemic

  • Thursday, 4 November, 2021
    InterviewTelevision
    ‘We’ve been screaming’: the makers of Dopesick on reframing the opioid crisis

    Writer Beth Macy and director Barry Levinson discuss taking on the Sacklers and victim-blaming in their mini-series

  • Wednesday, 1 September, 2021
    Purdue Pharma LP
    Sacklers shielded from future lawsuits in Purdue settlement

    Judge approves bankruptcy plan for opioid maker in which family will pay $4.5bn

  • Sunday, 8 August, 2021
    News in-depth
    Purdue’s bankruptcy deal shields Sackler family owners from future opioid liability

    Critics say concessions in case regarding the company diminishes accountability in overdose scandal

  • Wednesday, 21 July, 2021
    States unveil $26bn settlement to resolve opioid lawsuits

    US attorneys-general announce agreement with Johnson & Johnson and drug distribution giants

Previous page You are on page 1 Next page

Useful links

Support

View Site TipsHelp CentreContact UsAbout UsAccessibilitymyFT TourCareers

Legal & Privacy

Terms & ConditionsPrivacy PolicyCookiesCopyrightSlavery Statement & Policies

Services

Share News Tips SecurelyIndividual SubscriptionsGroup SubscriptionsRepublishingExecutive Job SearchAdvertise with the FTFollow the FT on TwitterFT ChannelsSecondary Schools

Tools

PortfolioToday's Newspaper (ePaper)Alerts HubBusiness School RankingsEnterprise ToolsNews feedNewslettersCurrency Converter

Community & Events

FT CommunityFT Live EventsFT ForumsFT Board DirectorBoard Director Programme

More from the FT Group

Markets data delayed by at least 15 minutes. © THE FINANCIAL TIMES LTD 2023. FT and ‘Financial Times’ are trademarks of The Financial Times Ltd.
The Financial Times and its journalism are subject to a self-regulation regime under the FT Editorial Code of Practice.
Financial Times

UK Edition

Subscribe for full access
  • Switch to International Edition

Top sections

  • Home
  • World
    • Global Economy
    • UK
    • US
    • China
    • Africa
    • Asia Pacific
    • Emerging Markets
    • Europe
    • War in Ukraine
    • Americas
    • Middle East & North Africa
    • Australia & NZ
  • UK
    • UK Business & Economy
    • UK Politics & Policy
    • Brexit
    • UK Companies
    • Personal Finance
  • Companies
    • Banks in turmoil
    • Energy
    • Financials
    • Health
    • Industrials
    • Media
    • Professional Services
    • Retail & Consumer
    • Tech Sector
    • Telecoms
    • Transport
  • Tech
  • Markets
    • Alphaville
    • Markets Data
    • Cryptofinance
    • Capital Markets
    • Commodities
    • Currencies
    • Equities
    • Fund Management
    • Trading
    • Moral Money
    • ETF Hub
  • Climate
  • Opinion
    • Columnists
    • The FT View
    • Lex
    • Obituaries
    • Letters
  • Work & Careers
    • Business School Rankings
    • Business Education
    • Entrepreneurship
    • Recruitment
    • Business Books
    • Business Travel
  • Life & Arts
    • Arts
    • Books
    • Food & Drink
    • FT Magazine
    • House & Home
    • Style
    • Travel
    • FT Globetrotter
  • Personal Finance
    • Property & Mortgages
    • Investments
    • Pensions
    • Tax
    • Banking & Savings
    • Advice & Comment
    • Next Act
  • HTSI
  • Special Reports

FT recommends

  • Lex
  • Alphaville
  • Lunch with the FT
  • FT Globetrotter
  • #techAsia
  • Moral Money
  • FTfm
  • Newsletters
  • Video
  • Podcasts
  • News feed
  • FT Live Events
  • FT Forums
  • Board Director Programme
  • myFT
  • Portfolio
  • Today's Newspaper (ePaper)
  • Crossword
  • Our Apps
  • Help Centre
  • Subscribe
  • Sign In